Dissociating β-Amyloid from α7 Nicotinic Acetylcholine Receptor by a Novel Therapeutic Agent, S 24795, Normalizes α7 Nicotinic Acetylcholine and NMDA Receptor Function in Alzheimer's Disease Brain

Alzheimer's disease (AD) is characterized by synaptic dysfunction and cardinal neuropathological features including amyloid plaques and neurofibrillary tangles. Soluble amyloid-β (Aβ) can suppress synaptic activities by interacting with α7 nicotinic acetylcholine receptors (α7nAChRs). Here, we...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Neurosci
Autors principals: Wang, Hoau-Yan, Stucky, Andres, Liu, JingJing, Shen, Changpeng, Trocme-Thibierge, Caryn, Morain, Philippe
Format: Artigo
Idioma:Inglês
Publicat: Society for Neuroscience 2009
Matèries:
Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6665534/
https://ncbi.nlm.nih.gov/pubmed/19726654
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1523/JNEUROSCI.6088-08.2009
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars